SPH Invitation and materials for a General shareholders meeting

Publication of materials
for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for October 30, 2026 and in the absence of a quorum on this date – for November 20, 2026 Sofia, Bulgaria, September 25, 2026 - According to the requirements of Art. 100t of the Law on Public Offering of Securities the Board of directors of “Sopharma” AD (SFA: “BSE“ AD, SPH: Warsaw Stock Exchange) presents the following materials on the agenda of EGM convened for October 30, 2026 and in the absence of a quorum on this date – for November 20, 2026, to the attention of shareholders, which will be available on the website of Extri News (www.x3news.com), in the FSC system, on the Company's website https://www.sopharmagroup.com/bg/investitori/korporativni-sabitia/obshto-sabranie-na-aktsionerite and on the website www.investor.bg, as well as in hard copy at the address of the Company: 1. Minutes of a meeting of the Board of Directors for convening an Extraordinary Meeting of Shareholders of “Sopharma” AD; 2. Invitation to convene the Extraordinary General Meeting of Shareholders (EGM) of “Sopharma” AD; 3. Power of attorney – an example for representing a shareholder at the EGM; 4. Declaration for voting by correspondence – an example for the EGM; 5. For item 1 of the agenda: Approval of the 6-month financial report for the first half of 2026– is already available on the website of Extri News (www.x3news.bg), in the FSC system, on the company's website and on the website www.investor.bg; 6. For item 2 of the agenda: Approval of a decision under Article 30, paragraphs 5-7 of the Company's Articles of Association for the distribution of profit and payment of an interim dividend based on the adopted 6-month financial report; 7. For item 3 of the agenda: Election of a registered auditor to perform a mandatory assurance engagement regarding the sustainability of the consolidated sustainability report of “Sopharma” AD for 2026, if applicable.